Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vistagen Therapeutics Inc
(NQ:
VTGN
)
3.800
UNCHANGED
Streaming Delayed Price
Updated: 11:34 AM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vistagen Therapeutics Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stocks That Hit 52-Week Lows On Friday
July 15, 2022
On Friday, 137 stocks made new 52-week lows.
Via
Benzinga
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Participate at 2022 Concordia Americas Summit; CEO and US Surgeon General to Discuss Mental Health Crisis
July 12, 2022
Via
Investor Brand Network
Exposures
COVID-19
VistaGen CEO Joins U.S. Surgeon General to Discuss Mental Health Crisis in America at the 2022 Concordia Americas Summit
July 12, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Participate at William Blair Biotech Focus Conference 2022
July 07, 2022
Via
Investor Brand Network
VistaGen to Participate at William Blair Biotech Focus Conference 2022
July 07, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
Week in Review: VectorBuilder Plans $500 Million Gene Therapy Delivery CDMO in Guangzhou
April 16, 2022
Deals, financings, trials and approvals in biotech in China this week.
Via
Talk Markets
Stocks That Hit 52-Week Lows On Tuesday
July 05, 2022
During Tuesday's session, 539 stocks hit new 52-week lows.
Via
Benzinga
Looking Into VistaGen Therapeutics's Return On Capital Employed
June 28, 2022
Benzinga Pro data, VistaGen Therapeutics (NASDAQ:VTGN) reported Q4 sales of $38.90 thousand. Earnings fell to a loss of $16.69 million, resulting in a 58.41% decrease from last quarter.
Via
Benzinga
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Corporate Update, FY 2022 Results
June 24, 2022
Via
Investor Brand Network
VistaGen Therapeutics Reports Fiscal Year 2022 Financial Results and Provides Corporate Update
June 23, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For June 23, 2022
June 23, 2022
Companies Reporting Before The Bell • Jerash Holdings (US) (NASDAQ:JRSH) is projected to report quarterly earnings at $0.07 per share on revenue of $30.14 million.
Via
Benzinga
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Completes PH94B PALISADE-1 Phase 3 Clinical Study for Acute Treatment of SAD
June 22, 2022
Via
Investor Brand Network
Earnings Preview For VistaGen Therapeutics
June 22, 2022
VistaGen Therapeutics (NASDAQ:VTGN) is set to give its latest quarterly earnings report on Thursday, 2022-06-23. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
VistaGen Announces Completion of PALISADE-1 Phase 3 Clinical Study of PH94B for the Acute Treatment of Social Anxiety Disorder
June 22, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Schedules Webcast to Announce FY 2022 Results
June 17, 2022
Via
Investor Brand Network
VistaGen Therapeutics to Report Fiscal Year 2022 Financial Results on June 23, 2022
June 17, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Wednesday
June 15, 2022
Wednesday's session saw 269 companies set new 52-week lows.
Via
Benzinga
InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) to Present Clinical Trial Abstract at ASCP Annual Meeting
June 02, 2022
Via
Investor Brand Network
Stocks That Hit 52-Week Lows On Monday
June 13, 2022
During Monday's trading, 1214 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 10, 2022
On Friday, 422 stocks made new 52-week lows.
Via
Benzinga
VistaGen to Present PH94B Exploratory Phase 2A Research Program for Adjustment Disorder with Anxiety at American Society for Clinical Psychopharmacology Annual Meeting
June 02, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Announces Participation in Top Investor Conferences
May 27, 2022
Via
Investor Brand Network
VistaGen to Participate in Upcoming June Investor Conferences
May 27, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
May 23, 2022
On Monday, 149 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
May 24, 2022
On Tuesday, 540 companies set new 52-week lows.
Via
Benzinga
7 Cheap Biotech Stocks to Buy Now
May 19, 2022
These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains.
Via
InvestorPlace
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Names New Chief Legal Officer
May 02, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
VistaGen Appoints Reid Adler as Chief Legal Officer
May 02, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Slated to Report Preclinical Data on Lead Candidate at Upcoming Scientific Congresses
April 21, 2022
Via
Investor Brand Network
VistaGen to Present Preclinical Data on Lead Candidate PH94B at Upcoming Scientific Congresses
April 21, 2022
From
VistaGen Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.